Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.21 +0.06 (+5.22%)
At close: Aug 20, 2026 · 4:00 PM EDT

Phio Pharmaceuticals (PHIO) Acquisitions (2017)

Phio Pharmaceuticals' (PHIO) quarterly Acquisitions came in at $100000.0 in Q1 2017.

Phio Pharmaceuticals (PHIO) Acquisitions (2017) Analysis & Trends

Phio Pharmaceuticals (PHIO) has 1 years of Acquisitions data on file, last reported at $100000.0 in Q1 2017.

  • Quarterly Acquisitions changed N/A year-over-year to $100000.0 in Q1 2017, while the trailing twelve-month figure through Dec 2017 was $100000.0 (changed N/A YoY) and the FY2017 annual result came in at $100000.0, changed N/A from the prior year.
  • Acquisitions held at $100000.0 in Q1 2017.
  • In the past five years, Acquisitions ranged from a high of $100000.0 in Q1 2017 to a low of $100000.0 in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -
10 Phio Pharmaceuticals 14.06 Mn 14.06 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2017 100,000.00